Advertisement

Topics

Companies Related to "Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma" [Most Relevant Company Matches] RSS

16:03 EST 15th February 2019 | BioPortfolio

Here are the most relevant search results for "Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Response Duration Toxicity Rituximab Fludarabine Cyclophosphamide Line" Companies 1–25 of 2,200+

Relevant

PURE Bioscience, Inc.

PURE Bioscience, Inc. develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE’s proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and le...


PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's ...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...


First Line Technology, LLC

First Line Technology, LLC supplies Out of the Box Solutions to first responders and the military. Since 2003, First Line has established itself as a leader in new product development and distribution with innovative, yet simple, solutions. First Line prides itself in creating high-quality products that are comfortable, effective, and safe for use in All-H...

Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

Molecular Response

Molecular Response is a leader in advancing targeted therapeutics through intelligently designed, clinically validated companion diagnostics. Our goal is to reduce risk and increase the efficacy of therapeutic drug development for our partners by translating clinically relevant molecular response marker data into high-value knowledge while fully integrated...

Agennix Incorporated

Agennix is developing this technology through the prototype stage in each application area. Prototype development includes overseeing the production of recombinant human lactoferrin, safety and toxicity studies and preclinical efficacy studies.

Church & Dwight, Co., Inc.

Church and Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response Early Result Pregnancy Test and other First Response products, including First Response Gold Digital, First Response Rapid Result Pregnancy Test, First Response Easy Read Ovulation Test, First Response Daily Ovulation Test, First Response Fertility Test for Women, and Answer Pregnancy and Ovulation Tests.

Pro-Pharmaceuticals, Inc.

Pro-Pharmaceuticals, OTCBB: PRWP, is the leader in the field of Galectin therapeutics and is engaged in the discovery, development and commercialization of therapeutics that target Galectin receptors for advanced treatment of cancer and fibrosis. Initially, the product pipeline is focused on increasing the efficacy and decreasing the toxicity of chemothera...

ex scientia Ltd.

ex scientia is a privately owned company developing new medicines for a wide range of human diseases where improved efficacy is required. ex scientia is the first company to develop a systematic algorithmic discovery platform to design molecules to a tailored polypharmacology or ‘bispecific’ target profile. Adopting this strategy increases the ef...

Dovetail Technologies Incorporated

Dovetail Technologies, Inc. is an Immuno-therapeutic and biotechnology discovery and development company focused on commercialization of proprietary technology platforms for Ultra High Potency / Ultra Low Toxicity immuno-therapeutics to develop drugs which power immune system response to disease, and, proprietary 2nd generation recombinant DNA technology to "surgically" design new and improved med...

VistaGen Therapeutics, Inc.

VistaGen Therapeutics is a biotechnology company focused on using proprietary pluripotent stem cell technology to discover, rescue and develop novel drug candidates for a broad range of diseases and conditions. VistaGen’s integrated stem cell technology platform, Human Clinical Trials in a Test Tube™, is based on the differentiation of human plur...

Response Mine Health

Response Mine Health is a premier, fully HIPAA compliant digital agency that helps health and wellness clients acquire more customers and patients using direct response digital marketing. For the past 15 years, Response Mine Health has generated millions of dollars in new revenue across healthcare companies including Liberty Medical, Hoveround, North Ameri...

Saladax Biomedical, Inc.

Saladax Biomedical develops novel diagnostic tests for the practical delivery of personalized medicine. The Company's products span all stages of development and address a variety of therapeutic areas, with an initial focus in oncology with its MYCARE™ platform. Saladax applies its validated technology platform to generate tests that increase efficacy...

ImaBiotech

Located in Europe (France), and North America (Cambridge, MA), ImaBiotech offers service with new imaging technologies, applications and software (Quantinetix™, Multimaging™). In order to accelerate drug development with innovative & proprietary imaging technologies, ImaBiotech offers Mass Spectrometry Imaging services to provide a cost effective...

Work Loss Data Institute

Work Loss Data Institute (WLDI) is “the evidence-based guideline company” and publisher of the ODG product line. ODG provides evidence-based decision support for managing medical treatment, disability duration, and utilization review in workers’ compensation, general health, and disability cases. ODG is available in Web-based and Systems Int...

Church and Dwight, Co., Inc.

Church & Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response(R) Early Result Pregnancy Test and other First Response(R) products, including First Response(R) Rapid Result Pregnancy Test, First Response(R) Easy Read Ovulation Test, and Answer Pregnancy and Ovulation Tests.

Supportive Solutions, Inc.

Supportive Solutions, Inc. (SSI) is dedicated to setting the standard for providing crisis response services to the business community while providing ongoing support and services to crisis consultants. Our approach to crisis response combines leading-edge practices with a commitment to excellence.To create standards of practice and deliver crisis response services that will be held up as a benchm...

Pro-Pharmaceuticals

Pro-Pharmaceuticals Inc. is a research leader in developing a new generation of Glyco-upgrade™ oncologic drugs. We target sugar-specific binding sites found on cancer cells using carbohydrate technology with the goal of improving efficacy and reducing toxicity of some of the proven, commonly used anti-cancer drugs.Two platforms of technologies have been identified by Pro- Pharmaceuticals. The fi...

International Therapeutics Incorporated

International Therapeutics, Inc. (ITI) is developing a novel anti-viral technology called Nuclear Importation Inhibition (NII) that may be applied against chronic viral disease such as HIV-1, hepatitis B (HBV), and herpes viruses. The technology is the subject of eight issued US patents and a series of foreign filings.The Company, started in 1999, has set up offices and laboratories in Seattle to ...

CytImmune

CytImmune is a clinical stage biopharmaceutical based in Rockville, MD. The Company is developing a pipeline of multifunctional, next-generation therapeutics, binding known anti-cancer agents – whose toxicities currently prevent or severely limit clinical use – to its patented colloidal gold tumor-targeting nanotechnology. This approach creates safe therapies for a broad spectrum of cancers,...

Response Mine Interactive

Response Mine Interactive (RMI) is a premier digital agency that helps health and wellness clients acquire more customers using direct response digital marketing. For the past 15 years, RMI has generated millions of dollars in new revenue across healthcare companies including Liberty Medical, Hoveround, North American Spine and MedExpress. For more informa...

Dovetail Technologies, Inc

Dovetail Technologies, Inc. is a biopharmaceutical development company innovating the development of Adaptive MicroMedicine™ immuno-therapeutics.Dovetail is focused on development and commercialization of proprietary Ultra High Potency / Ultra Low Toxicity immuno-therapeutic drugs that power immune system response to disease.Dovetail Technologies has developed and begun selling formulations of T...

Sinclair Pharma Limited

Sinclair Pharma is an international company operating in the fast growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive tre...

The Finish Line, Inc.

The Finish Line, Inc. is a premium retailer of athletic shoes, apparel and accessories. Based in Indianapolis, Finish Line has more than 635 stores in malls across the United States, employing more than 11,000 associates who help customers every day connect with their sport, their life and their style. Online shopping is available at www.finishline.com and...


More From BioPortfolio on "Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks